XML 56 R46.htm IDEA: XBRL DOCUMENT v3.25.2
Fair Value Measurements (Tables)
12 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Recorded Amounts of Major Financial Assets and Liabilities Measured at Fair Value on Recurring Basis
The following tables present recorded amounts of major financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2024 and 2025:
March 31, 2024
 
   
Millions of yen
 
   
Total

Carrying

Value in

Consolidated

Balance Sheets
   
Quoted Prices

in Active

Markets for

Identical Assets
or Liabilities

(Level 1)
   
Significant

Other

Observable

Inputs

(Level 2)
   
Significant

Unobservable

Inputs

(Level 3)
 
Assets:
       
Loans held for sale*1
  ¥ 129,959     ¥ 0     ¥ 33,393     ¥ 96,566  
Available-for-sale
debt securities:
    2,665,478       11,491       2,334,690       319,297  
Japanese and foreign government bond securities*2
    1,034,914       4,303       1,030,611       0  
Japanese prefectural and foreign municipal bond securities
    401,465       0       390,543       10,922  
Corporate debt securities*3
    844,579       7,188       831,805       5,586  
CMBS and RMBS in the Americas
    87,740       0       80,575       7,165  
Other asset-backed securities and debt securities
    296,780       0       1,156       295,624  
Equity securities*4*5
    415,607       108,964       143,786       162,857  
Derivative assets:
    72,986       52       66,433       6,501  
Interest rate swap agreements
    18,995       0       18,995       0  
Options held/written and other
    15,349       0       8,848       6,501  
Futures, foreign exchange contracts
    38,172       52       38,120       0  
Foreign currency swap agreements
    470       0       470       0  
Netting*6
    (47,496     —        —        —   
Net derivative assets
    25,490       —        —        —   
Other assets:
    2,786       0       0       2,786  
Reinsurance recoverables*7
    2,786       0       0       2,786  
 
 
 
   
 
 
   
 
 
   
 
 
 
Total
  ¥ 3,286,816     ¥ 120,507     ¥ 2,578,302     ¥ 588,007  
 
 
 
   
 
 
   
 
 
   
 
 
 
Liabilities:
       
Derivative liabilities:
  ¥ 95,686     ¥ 607     ¥ 90,862     ¥ 4,217  
Interest rate swap agreements
    3,728       0       3,728       0  
Options held/written and other
    14,394       0       10,177       4,217  
Futures, foreign exchange contracts
    70,997       607       70,390       0  
Foreign currency swap agreements
    6,563       0       6,563       0  
Credit derivatives written
    4       0       4       0  
Netting*6
    (47,496     —        —        —   
Net derivative Liabilities
    48,190       —        —        —   
Policy Liabilities and Policy Account Balances:
    167,207       0       0       167,207  
Variable annuity and variable life insurance contracts*8
    167,207       0       0       167,207  
Accounts Payable
    14,136       0       0       14,136  
Contingent Consideration
    14,136       0       0       14,136  
 
 
 
   
 
 
   
 
 
   
 
 
 
Total
  ¥ 277,029     ¥ 607     ¥ 90,862     ¥ 185,560  
 
 
 
   
 
 
   
 
 
   
 
 
 
 
March 31, 2025
 
   
Millions of yen
 
   
Total

Carrying

Value in

Consolidated

Balance Sheets
   
Quoted Prices

in Active

Markets for

Identical Assets
or Liabilities

(Level 1)
   
Significant

Other

Observable

Inputs

(Level 2)
   
Significant

Unobservable

Inputs

(Level 3)
 
Assets:
       
Loans held for sale*1
  ¥ 97,694     ¥ 0     ¥ 29,900     ¥ 67,794  
Available-for-sale
debt securities:
    2,607,637       12,243       2,377,740       217,654  
Japanese and foreign government bond securities*2
    1,092,526       7,510       1,085,016       0  
Japanese prefectural and foreign municipal bond securities
    406,830       0       395,952       10,878  
Corporate debt securities*3
    802,545       4,733       793,560       4,252  
CMBS and RMBS in the Americas
    106,751       0       99,669       7,082  
Other asset-backed securities and debt securities
    198,985       0       3,543       195,442  
Equity securities*4*5
    418,690       137,014       119,466       162,210  
Derivative assets:
    64,170       361       54,992       8,817  
Interest rate swap agreements
    17,869       0       17,869       0  
Options held/written and other
    15,767       0       6,950       8,817  
Futures, foreign exchange contracts
    20,964       361       20,603       0  
Foreign currency swap agreements
    9,570       0       9,570       0  
Netting*6
    (20,495     —        —        —   
Net derivative assets
    43,675       —        —        —   
Other assets:
    2,586       0       0       2,586  
Reinsurance recoverables*7
    2,586       0       0       2,586  
 
 
 
   
 
 
   
 
 
   
 
 
 
Total
  ¥ 3,190,777     ¥ 149,618     ¥ 2,582,098     ¥ 459,061  
 
 
 
   
 
 
   
 
 
   
 
 
 
Liabilities:
       
Derivative liabilities:
  ¥ 56,038     ¥ 129     ¥ 55,257     ¥ 652  
Interest rate swap agreements
    2,774       0       2,774       0  
Options held/written and other
    13,715       0       13,063       652  
Futures, foreign exchange contracts
    39,387       129       39,258       0  
Foreign currency swap agreements
    159       0       159       0  
Credit derivatives written
    3       0       3       0  
Netting*6
    (20,495     —        —        —   
Net derivative Liabilities
    35,543       —        —        —   
Policy Liabilities and Policy Account Balances:
    136,257       0       0       136,257  
Variable annuity and variable life insurance contracts*8
    136,257       0       0       136,257  
Accounts Payable
    15,259       0       0       15,259  
Contingent Consideration
    15,259       0       0       15,259  
 
 
 
   
 
 
   
 
 
   
 
 
 
Total
  ¥ 207,554     ¥ 129     ¥ 55,257     ¥ 152,168  
 
 
 
   
 
 
   
 
 
   
 
 
 
 
*1
A certain subsidiary elected the fair value option on certain loans held for sale. These loans are multi-family and seniors housing loans and are sold to Federal National Mortgage Association (“Fannie Mae”), Federal Home Loan Mortgage Corporation (“Freddie Mac”) and institutional investors. Included in “Other (income) and expense” in the consolidated statements of income were a loss of ¥2,429 million, a gain of ¥428 
million and a loss of ¥1,052 million from the change in the fair value of the loans for fiscal 2023, 2024 and 2025, 
 
respectively. No gains or losses were recognized in earnings during fiscal 2023, 2024 and 2025 attributable to changes in instrument-specific credit risk. The amounts of aggregate unpaid principal balance and aggregate fair value of the loans held for sale as of March 31, 2024, were ¥130,554 million and ¥129,959 million, respectively, and the amount of the aggregate fair value was less than the amount of aggregate unpaid principal balance by ¥595 million. The amounts of aggregate unpaid principal balance and aggregate fair value of the loans held for sale as of March 31, 2025, were ¥98,135 million and ¥97,694 million, respectively, and the amount of the aggregate fair value was less than the amount of aggregate unpaid principal balance by ¥441 million. As of March 31, 2024, there were no loans that are 90 days or more past due or, in non-accrual status. The amounts of aggregate unpaid principal balance and aggregate fair value of loans that are 90 days or more past due or, in non-accrual status as of March 31, 2025, were ¥17,098 million and ¥16,346 million, respectively, and the amount of the aggregate fair value was less than the amount of aggregate unpaid principal balance by ¥752 million.
*2
A certain subsidiary elected the fair value option for investments in foreign government bond securities included in
available-for-sale
debt securities. Included in “Gains on investment securities and dividends” in the consolidated statements of income were losses of ¥11 million, ¥6 million and ¥59 million from the change in the fair value of those investments for fiscal 2023, 2024 and 2025, respectively. The amount of aggregate fair value elected the fair value option were ¥1,000 million and ¥5,379 million as of March 31, 2024 and 2025, respectively.
*3
A certain subsidiary elected the fair value option for investments in foreign corporate debt securities included in
available-for-sale
debt securities. Included in “Gains on investment securities and dividends” in the consolidated statements of income were a loss of ¥516 million, gains of ¥399 million and ¥441 million from the change in the fair value of those investments for fiscal 2023, 2024 and 2025, respectively. The amounts of aggregate fair value elected the fair value option were ¥7,751 million and ¥10,679 million as of March 31, 2024 and 2025, respectively.
*4
Certain subsidiaries elected the fair value option for certain investments in investment funds and others included in equity securities. Included in “Gains on investment securities and dividends” and “Life insurance premiums and related investment income” in the consolidated statements of income were gains of ¥1,066 million, ¥3,269 million and ¥1,954 million from the change in the fair value of those investments for fiscal 2023, 2024 and 2025, respectively. The amounts of aggregate fair value elected the fair value option were ¥26,945 million and ¥24,960 million as of March 31, 2024 and 2025, respectively.
*5
The amounts of investment funds measured at net asset value per share which are not included in the above tables were ¥85,280 million and ¥118,666 million as of March 31, 2024 and 2025, respectively.
*6
It represents the amount offset under counterparty netting of derivative assets and liabilities.
*7
Certain subsidiaries elected the fair value option for certain reinsurance contracts held. The fair value of the reinsurance contracts elected for the fair value option in other assets were ¥2,786 million and ¥2,586 million as of March 31, 2024 and 2025, respectively. For the effect of changes in the fair value of those reinsurance contracts on earnings for fiscal 2023, 2024 and 2025, see Note 23 “Income and Expenses Relating to Life Insurance Operations.”
*8
Certain subsidiaries elected the fair value option for the entire variable annuity and variable life insurance contracts held. The fair value of the variable annuity and variable life insurance contracts elected for the fair value option in policy liabilities and policy account balances were ¥167,207 million and ¥136,257 million as of March 31, 2024 and 2025, respectively. For the effect of changes in the fair value of the variable annuity and variable life insurance contracts on earnings for fiscal 2023, 2024 and 2025, see Note 23 “Income and Expenses Relating to Life Insurance Operations.”
Reconciliation of Financial Assets and Liabilities (Net) Measured at Fair Value on Recurring Basis Using Significant Unobservable Input
The following tables present the reconciliation of financial assets and liabilities (net) measured at fair value on a recurring basis using significant unobservable inputs (Level 3) in fiscal 2023, 2024 and 2025:
2023
 
   
Millions of yen
 
   
Balance at

April 1,

2022
   
Gains or losses

(realized/unrealized)
   
Purchases*3
   
Sales
   
Settlements*4
   
Transfers

in and/

or out of

Level 3

(net)
   
Balance at

March 31,

2023
   
Change in

unrealized

gains or losses

included in

earnings for

assets and

liabilities still

held at

March 31,

2023*1
   
Change in

unrealized

gains or losses

included in

other
comprehensive
income for

assets and

liabilities still

held at

March 31,

2023*2
 
 
Included in

earnings*1
   
Included in

other

comprehensive

income*2
   
Total
 
Loans held for sale
  ¥ 0     ¥ 18     ¥  1,095     ¥  1,113     ¥ 2,457     ¥ (5,776   ¥ 0     ¥ 176,055     ¥ 173,849     ¥ 18     ¥ 1,095  
Available-for-sale
debt securities
    141,060       3,788       1,238       5,026       116,175       (9,100     (9,559     0       243,602       3,458       1,713  
Japanese prefectural and foreign municipal bond securities
    3,053       0       278       278       0             0       0       0       3,331       0       278  
Corporate debt securities
    697       89       (1     88       5,922       (1,554     (416     0       4,737       (16     (0
Other asset-backed securities and debt securities
    137,310       3,699       961       4,660       110,253       (7,546     (9,143     0       235,534       3,474       1,435  
Equity securities
    112,972       22,823       9,647       32,470       7,191       (7,223     (2,336     0       143,074       22,113       9,514  
Investment funds
    112,972          22,823       9,647       32,470       7,191       (7,223     (2,336     0       143,074       22,113       9,514  
Derivative assets and liabilities (net)
    (3,772     (2,845     (1,207     (4,052     0       0       0       0       (7,824     (2,845     (1,207
Options held/written and other
    (3,772     (2,845     (1,207     (4,052     0       0       0       0       (7,824     (2,845     (1,207
Other asset
    5,214       (1,286     0       (1,286     1,153       0       (405     0       4,676       (1,286     0  
Reinsurance recoverables*5
    5,214       (1,286     0       (1,286     1,153       0       (405     0       4,676       (1,286     0  
Policy Liabilities and Policy Account Balances
    198,905       6,343       74       6,417       0       0       (28,754     0       163,734       6,343       74  
Variable annuity and variable life insurance contracts*6
    198,905       6,343       74       6,417       0       0       (28,754     0       163,734       6,343       74  
 
2024
 
   
Millions of yen
 
   
Balance at

April 1,

2023
   
Gains or losses

(realized/unrealized)
   
Purchases*3
   
Sales
   
Settlements*4
   
Transfers

in and/

or out of

Level 3

(net)
   
Balance at

March 31,

2024
   
Change in

unrealized

gains or losses

included in

earnings for

assets and

liabilities still

held at

March 31,

2024*1
   
Change in

unrealized

gains or losses

included in

other
comprehensive
income for

assets and

liabilities still

held at

March 31,

2024*2
 
 
Included in

earnings*1
   
Included in

other

comprehensive

income*2
   
Total
 
Loans held for sale
  ¥ 173,849     ¥ 566     ¥ 18,937     ¥ 19,503     ¥ 4,467     ¥ (66,078   ¥ (35,175   ¥ 0     ¥ 96,566     ¥ 0     ¥ 18,937  
Available-for-sale
debt securities
    243,602       13,906       17,117       31,023        68,295       (15,041     (15,400     6,818       319,297       12,918       18,018  
Japanese prefectural and foreign municipal bond securities
    3,331       (75     866       791       0       0       (18     6,818       10,922       (75     809  
Corporate debt securities
    4,737       974       1       975       14       0       (140     0       5,586       608       1  
CMBS and RMBS in the Americas
    0       0       286       286       6,879       0       0       0       7,165       0       282  
Other asset-backed securities and debt securities
    235,534       13,007       15,964       28,971       61,402       (15,041     (15,242     0       295,624       12,385       16,926  
Equity securities
    143,074       (841     18,617       17,776       4,675       (495     (2,173     0       162,857       (1,097     18,617  
Investment funds
    143,074       (841     18,617       17,776       4,675       (495     (2,173     0       162,857       (1,097     18,617  
Derivative assets and liabilities (net)
    (7,824     10,595       (487     10,108       0       0       0       0       2,284       10,595       (487
Options held/written and other
    (7,824     10,595       (487     10,108       0       0       0       0       2,284       10,595       (487
Other asset
    4,676       (2,711     0       (2,711     971       0       (150     0       2,786       (2,711     0  
Reinsurance recoverables*5
    4,676       (2,711     0       (2,711     971       0       (150     0       2,786       (2,711     0  
Policy Liabilities and Policy Account Balances
    163,734       (30,205     (265     (30,470     0       0       (26,997     0       167,207       (30,205     (265
Variable annuity and variable life insurance contracts*6
    163,734       (30,205     (265     (30,470     0       0       (26,997     0       167,207       (30,205     (265
Accounts Payable:
    12,576       (47     (1,513     (1,560     0       0       0       0       14,136       (47     (1,513
Contingent Consideration
    12,576       (47     (1,513     (1,560     0       0       0       0       14,136       (47     (1,513
2025
 
   
Millions of yen
 
 
Balance at

April 1,

2024
   
Gains or losses

(realized/unrealized)
   
Purchases*3
   
Sales
   
Settlements*4
   
Transfers

in and/

or out of

Level 3

(net)
   
Balance at

March 31,

2025
   
Change in

unrealized

gains or losses

included in

earnings for

assets and

liabilities still

held at

March 31,

2025*1
   
Change in

unrealized

gains or losses

included in

other
comprehensive
income for

assets and

liabilities still

held at

March 31,

2025*2
 
 
Included in

earning
s *1
   
Included in

other

comprehensive

income*2
   
Total
 
Loans held for sale
  ¥ 96,566      ¥ (1,778 )     ¥ (543 )     ¥ (2,321 )     ¥ 633     ¥ 0      ¥ (27,084   ¥ 0     ¥ 67,794     ¥ (708   ¥ (543
Available-for-sale
debt securities
    319,297       1,336       (1,437     (101     99,785       (56,749     (144,578 )     0       217,654       370       (463
Japanese prefectural and foreign municipal bond securities
    10,922       (107     82       (25     0       0       (19     0       10,878       (107     82  
Corporate debt securities
    5,586       235       (17     218       300       (1,712     (140     0       4,252       (73     (17
CMBS and RMBS in the Americas
    7,165       0       (83     (83     0       0       0       0       7,082       0       (83
Other asset-backed securities and debt securities
    295,624       1,208       (1,419     (211     99,485       (55,037     (144,419 )     0       195,442       550       (445
Equity securities
    162,857       (8,129     (2,089     (10,218     20,113       (656     (9,886     0       162,210       (8,163     (2,099
Investment funds and other
    162,857       (8,129     (2,089     (10,218     20,113       (656     (9,886     0       162,210       (8,163     (2,099
Derivative assets and liabilities (net)
    2,284       5,480       401       5,881       0       0       0       0       8,165       5,480       401  
Options held/written and other
    2,284       5,480       401       5,881       0       0       0       0       8,165       5,480       401  
Other asset
    2,786       (1,027     0       (1,027     916       0       (89     0       2,586       (1,027     0  
Reinsurance recoverables*5
    2,786       (1,027     0       (1,027     916       0       (89     0       2,586       (1,027     0  
Policy Liabilities and Policy Account Balances
    167,207       7,292       (48     7,244       0       0       (23,706     0       136,257       7,292       (48
Variable annuity and variable life insurance contracts*6
    167,207       7,292       (48     7,244       0       0       (23,706     0       136,257       7,292       (48
Accounts Payable:
    14,136       (1,235     112       (1,123     0       0       0       0       15,259       (1,235     112  
Contingent Consideration
    14,136       (1,235     112       (1,123     0       0       0       0       15,259       (1,235     112  
 
 
*1
Principally, gains and losses from
available-for-sale
debt securities are included in “Gains on investment securities and dividends”, “Write-downs of securities” or “Life insurance premiums and related investment income”; equity securities are included in “Gains on investment securities and dividends” and “Life insurance premiums and related investment income” and loans held for sale, derivative assets and liabilities (net), and accounts payable are included in “Other (income) and expense” respectively. Additionally, for
available-for-sale
debt securities, amortization of interest recognized in finance revenues is included in these columns.
*2
Unrealized gains and losses from loans held for sale are included in “Net change of foreign currency translation adjustments”, unrealized gains and losses from
available-for-sale
debt securities are included in “Net change of unrealized gains (losses) on investment in securities” and “Net change of foreign currency translation adjustments”, unrealized gains and losses from equity securities and derivative assets and liabilities (net) are included mainly in “Net change of foreign currency translation adjustments”, unrealized gains and losses from policy liabilities and policy account balances are included in “Net change of debt valuation adjustments.”, unrealized gains and losses from accounts payable are included in “Net change of foreign currency translation adjustments”.
*3
Increases resulting from an acquisition of a subsidiary and insurance contracts ceded to reinsurance companies are included.
*4
Decreases resulting from the receipts of reimbursements for benefits, and decreases resulting from insurance payouts to variable annuity and variable life policyholders due to death, surrender and maturity of the investment period are included.
*5
“Included in earnings” in the above table includes changes in the fair value of reinsurance contracts recorded in “Life insurance costs” and reinsurance premiums, net of reinsurance benefits received, recorded in “Life insurance premiums and related investment income.”
*6
“Included in earnings” in the above table is recorded in “Life insurance costs” and includes changes in the fair value of policy liabilities and policy account balances resulting from gains or losses on the underlying investment assets managed on behalf of variable annuity and variable life policyholders, and the changes in the minimum guarantee risks relating to variable annuity and variable life insurance contracts as well as insurance costs recognized for insurance and annuity payouts as a result of insured events. For the information about policy account balances for variable annuity and variable life insurance contracts and market risk benefits as of and for the fiscal year ended March 31, 2024 and 2025, see Note 24 “Long-Duration Insurance Contracts Relating to Life Insurance Operations.”
Recorded Amounts of Major Assets Measured at Fair Value on Nonrecurring Basis
The following tables present recorded amounts of assets measured at fair value on a nonrecurring basis during fiscal 2024 and 2025. These assets are measured at fair value on a nonrecurring basis mainly to recognize impairment:
2024
 
    
Millions of yen
 
    
Total

Carrying

Value in

Consolidated

Balance
Sheets
    
Quoted Prices

in Active

Markets for

Identical
Assets

(Level 1)
    
Significant

Other

Observable

Inputs

(Level 2)
    
Significant

Unobservable

Inputs

(Level 3)
 
Assets:
           
Loans held for sale
   ¥ 1,706      ¥ 0      ¥ 1,706      ¥ 0  
Real estate collateral-dependent loans (net of allowance for credit losses)
     5,535        0        261        5,274  
Investment in operating leases and property under facility operations
     1,205        0        0        1,205  
Certain equity securities
     18,484        0        18,484        0  
Certain equity method investments
     461        0        0        461  
  
 
 
    
 
 
    
 
 
    
 
 
 
   ¥ 27,391      ¥     0      ¥ 20,451      ¥ 6,940  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
2025
 
 
  
Millions of yen
 
 
  
Total

Carrying

Value in

Consolidated

Balance
Sheets
 
  
Quoted Prices

in Active

Markets for

Identical
Assets

(Level 1)
 
  
Significant

Other

Observable

Inputs

(Level 2)
 
  
Significant

Unobservable

Inputs

(Level 3)
 
Assets:
  
  
  
  
Real estate collateral-dependent loans (net of allowance for credit losses)
  
¥
5,881
 
  
¥
0
 
  
¥
0
 
  
¥
5,881
 
Investment in operating leases, property under facility operations and office facilities
  
 
8,105
 
  
 
0
 
  
 
0
 
  
 
8,105
 
Certain equity securities
  
 
15,193
 
  
 
0
 
  
 
15,193
 
  
 
0
 
Certain equity method investments
  
 
20,619
 
  
 
0
 
  
 
0
 
  
 
20,619
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
¥
49,798
 
  
¥
    0
 
  
¥
15,193
 
  
¥
34,605
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Information about the valuation techniques and significant unobservable inputs used in the valuation of Level 3 assets and liabilities measured at fair value on a recurring basis
The following tables provide information about the valuation techniques and significant unobservable inputs used in the valuation of Level 3 assets and liabilities measured at fair value on a recurring basis as of March 31, 2024 and 2025.
 
    
March 31, 2024
 
    
Millions of
yen
    
Valuation technique(s)
  
Significant
unobservable inputs
  
Range

(Weighted average)
 
    
Fair value
 
Assets:
           
Loans held for sale
   ¥ 96,566      Discounted cash flows    Discount rate      7.7% – 13.0%  
              (10.0%)  
Available-for-sale
debt securities:
           
Japanese prefectural and foreign municipal bond securities
     7,145      Discounted cash flows    Discount rate     
4.9% – 10.5%
(5.8%)
 
 
     3,777      Appraisals/Broker quotes    —       —   
Corporate debt securities
     140      Discounted cash flows    Discount rate      0.4%  
             
(
0.4
%)
 
     5,446      Appraisals/Broker quotes    —       —   
CMBS and RMBS in the Americas
     7,165      Appraisals/Broker quotes    —       —   
Other asset-backed securities and debt securities
     28,391      Discounted cash flows    Discount rate      0.3% – 51.2%  
             
(
6.7
%)
 
         Probability of default      1.9%  
              (1.9%)  
     267,233      Appraisals/Broker quotes    —       —   
Equity securities:
           
Investment funds
     131,907      Discounted cash flows    WACC      12.8% – 26.4%  
             
(
17.2
%)
 
         EV/Terminal EBITDA multiple     
7.5x-12.0x
 
             
(
9.5
x)
 
      Market multiples    EV/Last twelve months EBITDA multiple     
8.1x-9.5x
 
             
(
8.8
x)
 
         EV/Forward EBITDA multiple     
6.8x-9.6x
 
             
(
8.2
x)
 
         EV/Precedent transaction last twelve months EBITDA multiple     
8.0x-13.0x
 
             
(
9.9
x)
 
     24,668      Appraisals/Broker quotes    —       —   
     6,282      Discounted cash flows    Discount rate      8.0% – 12.0%  
             
(
10.3
%)
 
Derivative assets:
           
Options held/written and other
     6,501      Discounted cash flows    Discount rate      12.0% – 33.0%  
             
(
14.6
%)
 
Other assets:
           
Reinsurance recoverables
     2,786      Discounted cash flows    Discount rate      (0.1)% – 1.6%  
              (0.5%)  
         Mortality rate      0.0% – 100.0%  
              (2.9%)  
         Lapse rate      1.5% – 14.0%  
              (4.8%)  
        
Annuitization rate
(guaranteed minimum annuity benefit)
     100.0%  
              (100.0%)  
  
 
 
          
Total
   ¥ 588,007           
  
 
 
          
Liabilities:
           
Derivative liabilities:
           
Options held/written and other
   ¥ 4,198      Discounted cash flows    Discount rate      12.0% – 33.0%  
             
(
14.6
%)
 
     19      Appraisals/Broker quotes    —       —   
Policy liabilities and Policy Account Balances:
           
Variable annuity and variable life insurance contracts
     167,207      Discounted cash flows    Discount rate      (0.1)% – 1.6%  
              (0.5%)  
         Mortality rate      0.0% – 100.0%  
              (2.1%)  
         Lapse rate      1.5% – 30.0%  
              (5.9%)  
        
Annuitization rate
(guaranteed minimum annuity benefit)
     0.0% – 100.0%  
             
(
66.7
%)
 
  
 
 
          
Accounts Payable:
           
Contingent Consideration
     14,136      Discounted cash flows    EV/Terminal EBITDA multiple      15.0x  
             
(
15.0
x)
 
  
 
 
          
Total
   ¥ 185,560           
  
 
 
          
 
    
March 31, 2025
 
    
Millions of
yen
    
Valuation technique(s)
  
Significant
unobservable inputs
  
Range

(Weighted average)
 
    
Fair value
 
Assets:
           
Loans held for sale
   ¥ 67,794      Discounted cash flows    Discount rate      7.0% – 12.1%  
              (9.4%)  
Available-for-sale
debt securities:
           
Japanese prefectural and foreign municipal bond securities
     6,319      Discounted cash flows    Discount rate      5.8% – 9.8%  
              (8.0%)  
     4,559      Appraisals/Broker quotes    —       —   
Corporate debt securities
     302      Discounted cash flows    Discount rate      1.5%  
             
(
1.5
%
)
 
     3,950      Appraisals/Broker quotes    —       —   
CMBS and RMBS in the Americas
     7,082      Appraisals/Broker quotes    —       —   
Other asset-backed securities and debt securities
     34,670      Discounted cash flows    Discount rate      0.4% – 51.2%  
             
(
5.5
%)
 
         Probability of default      0.2%  
              (0.2%)  
     160,772      Appraisals/Broker quotes    —       —   
Equity securities:
           
Investment funds
 and other
     133,585      Discounted cash flows    WACC      13.3% – 23.7%  
             
(
16.8
%)
 
         EV/Terminal EBITDA multiple     
4.2x-12x
 
             
(
8.8
x)
 
      Market multiples    EV/Last twelve months EBITDA multiple      4.3x-9.5x  
             
(
7.8
x)
 
         EV/Forward EBITDA multiple      4.2x-9x  
             
(
7.7
x)
 
         EV/Precedent transaction last twelve months EBITDA multiple     
4.3x-11.9x
 
             
(
8.7
x)
 
     22,859      Appraisals/Broker quotes    —       —   
     5,766      Discounted cash flows    Discount rate      11.5% – 12.0%  
             
(
11.7
%)
 
Derivative assets:
           
Options held/written and other
     8,297      Discounted cash flows    Discount rate      12.0% – 33.0%  
             
(
14.7
%)
 
     520      Appraisals/Broker quotes    —       —   
Other assets:
           
Reinsurance recoverables
     2,586      Discounted cash flows    Discount rate      0.5% – 2.4%  
              (1.3%)  
         Mortality rate      0.0% – 100.0%  
              (2.9%)  
         Lapse rate      1.5% – 14.0%  
              (4.7%)  
        
Annuitization rate
(guaranteed minimum annuity benefit)
     100.0%  
              (100.0%)  
  
 
 
          
Total
   ¥ 459,061           
  
 
 
          
Liabilities:
           
Derivative liabilities:
           
Options held/written and other
   ¥ 652      Discounted cash flows    Discount rate      12.0% – 33.0%  
             
(
14.7
%)
 
Policy liabilities and Policy Account Balances:
           
Variable annuity and variable life insurance contracts
     136,257      Discounted cash flows    Discount rate      0.5% – 2.4%  
              (1.3%)  
         Mortality rate      0.0% – 100.0%  
              (2.3%)  
         Lapse rate      1.5% – 30.0%  
              (5.7%)  
        
Annuitization rate
(guaranteed minimum annuity benefit)
     0.0% – 100.0%  
             
(
67.1
%)
 
  
 
 
          
Accounts Payable:
           
Contingent Consideration
     15,259      Discounted cash flows    EV/Terminal EBITDA multiple      15.0x  
             
(
15.0x)
 
  
 
 
          
Total
   ¥ 152,168           
  
 
 
          
Information about Valuation Techniques and Significant Unobservable Inputs Used in Valuation of Level Three Assets Measured at Fair Value on Nonrecurring Basis
The following tables provide information about the valuation techniques and significant unobservable inputs used in the valuation of Level 3 assets measured at fair value on a nonrecurring basis during fiscal 2024 and 2025.
 
    
2024
    
Millions of
yen
    
Valuation technique(s)
  
Significant
unobservable inputs
  
Range

(Weighted average)
    
Fair value
 
Assets:
           
Real estate collateral-dependent loans (net of allowance for credit losses)
   ¥ 892      Direct capitalization    Capitalization rate          4.6% – 6.3%  
           
(
5.3
%)
       4,382     
Appraisals/Broker quotes
   —     — 
Investment in operating leases and property under facility operations
     337      Discounted cash flows    Discount rate    0.0% – 13.0%
           
(
3.6
%
)
     868     
Appraisals/Broker quotes
   —     — 
Certain equity method investments
     461      Market multiples    EV/EBITDA multiple   
3x-6x
           
(
4.5x)
  
 
 
          
   ¥ 6,940           
  
 
 
          
    
2025
    
Millions of
yen
    
Valuation technique(s)
  
Significant
unobservable inputs
  
Range

(Weighted average)
    
Fair value
 
Assets:
           
Real estate collateral-dependent loans (net of allowance for credit losses)
   ¥ 1,064      Direct capitalization    Capitalization rate          4.4% – 5.2%  
           
(
4.7
%)
       4,817     
Appraisals/Broker quotes
   —     — 
Investment in operating leases, property under facility operations and office facilities
     3,314     
Discounted cash flows
  
Discount rate

  
6.1%
 
 
 
 
 
 
 
 
 
  
(
6.1%
)
 
 
 
4,791
 
  
Appraisals/Broker quotes
   —     — 
Certain equity method investments
     20,619     
Appraisals/Broker quotes
   —     — 
  
 
 
          
   ¥ 34,605